Health Catalyst, Inc. (NASDAQ:HCAT) Sees Large Decrease in Short Interest

Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) was the target of a significant decrease in short interest in January. As of January 31st, there was short interest totalling 2,010,000 shares, a decrease of 21.5% from the January 15th total of 2,560,000 shares. Based on an average daily trading volume, of 656,600 shares, the days-to-cover ratio is currently 3.1 days.

Insiders Place Their Bets

In other news, General Counsel Benjamin Landry sold 19,268 shares of the company's stock in a transaction dated Friday, December 6th. The shares were sold at an average price of $8.32, for a total value of $160,309.76. Following the sale, the general counsel now directly owns 72,250 shares of the company's stock, valued at $601,120. This represents a 21.05 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Kevin Lee Freeman sold 7,500 shares of the firm's stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $8.94, for a total value of $67,050.00. Following the transaction, the insider now owns 236,950 shares of the company's stock, valued at $2,118,333. The trade was a 3.07 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 81,169 shares of company stock valued at $629,068 over the last quarter. 2.50% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the business. PharVision Advisers LLC acquired a new stake in shares of Health Catalyst in the fourth quarter valued at approximately $185,000. Two Sigma Advisers LP grew its position in Health Catalyst by 72.7% during the 4th quarter. Two Sigma Advisers LP now owns 29,700 shares of the company's stock worth $210,000 after purchasing an additional 12,500 shares during the last quarter. Two Sigma Investments LP acquired a new position in Health Catalyst in the fourth quarter valued at $496,000. ProShare Advisors LLC raised its holdings in shares of Health Catalyst by 52.7% in the fourth quarter. ProShare Advisors LLC now owns 16,854 shares of the company's stock valued at $119,000 after buying an additional 5,815 shares during the last quarter. Finally, Group One Trading LLC boosted its stake in shares of Health Catalyst by 107.6% during the fourth quarter. Group One Trading LLC now owns 4,360 shares of the company's stock worth $31,000 after buying an additional 2,260 shares during the period. 85.00% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on HCAT shares. KeyCorp upgraded shares of Health Catalyst from a "sector weight" rating to an "overweight" rating and set a $9.00 price objective on the stock in a research note on Wednesday, January 8th. Royal Bank of Canada reduced their price objective on shares of Health Catalyst from $9.00 to $7.00 and set a "sector perform" rating on the stock in a research report on Wednesday, January 15th. Stephens raised their price objective on Health Catalyst from $7.00 to $9.00 and gave the company an "equal weight" rating in a research report on Thursday, November 14th. Piper Sandler decreased their target price on shares of Health Catalyst from $12.00 to $8.00 and set an "overweight" rating on the stock in a research report on Tuesday, February 11th. Finally, Wells Fargo & Company reduced their target price on shares of Health Catalyst from $13.00 to $10.00 and set an "overweight" rating on the stock in a research note on Tuesday, January 21st. Two equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $10.20.

Health Catalyst Stock Up 2.8 %

Shares of NASDAQ HCAT traded up $0.15 during midday trading on Wednesday, hitting $5.55. The company's stock had a trading volume of 857,506 shares, compared to its average volume of 784,772. Health Catalyst has a 1 year low of $5.25 and a 1 year high of $9.89. The business's fifty day simple moving average is $6.35 and its two-hundred day simple moving average is $7.31. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.41 and a quick ratio of 1.41. The firm has a market capitalization of $337.72 million, a price-to-earnings ratio of -4.11 and a beta of 1.34.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.